eoe sub articles

EoE Sub Articles

All procedures involving human participants have been performed in compliance with the institutional, national, and international guidelines for human welfare and have been reviewed by the local institutional review board
1. Isolation and Purification of Human Peripheral Blood B Cells
<ol>
	<li>Draw ~ 10 mL of blood from the median cubital vein (in the cubital fossa anterior to the elbow) into a 15-mL tube containing K2EDTA (1.5 to 2.0 mg/mL blood) and immediately invert the tube several times to prevent clot formation.</li>
	<li>Add 35 mL of autoclaved (121 &#176;C, 15 min) red blood cell (RBC) lysis buffer (150 mM NH4Cl, 10 mM KHCO3, and 1 mM EDTA; pH 7.4) to the tube containing the fresh blood sample (&#8805; 3:1 vol/vol) and incubate at room temperature (RT) for no longer than 5 min. 
	NOTE: The appearance of light transmission through the tube indicates the completion of RBC lysis.</li>
	<li>Centrifuge at 600 x g at RT for 5 min. Ensure that the pellet is white in color.</li>
	<li>Resuspend the pellet with 10 mL of autoclaved phosphate-buffered saline (PBS, 137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, and 1.47 mM KH2PO4; pH 7.4) and centrifuge as in step 1.3.</li>
	<li>Discard the supernatant, resuspend the pellet with 10 mL of RPMI 1640 medium (supplements: 10% fetal calf serum, 100 U/mL penicillin/streptomycin, 0.25 &#181;g/mL amphotericin B, and 2 mM L-glutamine), and then plate the cells into a 10-cm culture dish (10 mL of blood per dish). Place the dish in a 37 &#176;C incubator with 5% CO2 for 30 min.</li>
	<li>Gently swirl the culture dish a few times and place the culture medium (suspension cells) into 15-mL plastic conical tubes. Discard the adherent cells (mostly macrophages) on the culture dishes.</li>
	<li>Centrifuge at 600 x g at RT for 5 min. Discard the supernatant.</li>
	<li>Resuspend the pellet with 1 mL of RPMI 1640 medium. Count the cell number with a hemocytometer or an automated cell counter. 
	NOTE: The viability of isolated leukocytes is normally greater than 90% by trypan blue exclusion.</li>
	<li>Centrifuge as in step 1.7 and resuspend the cells in ~ 200 &#181;L of cold PBS buffer (0.5% bovine serum albumin (BSA) and 2 mM EDTA) at the concentration of 5 - 10 x 106 cells/mL.</li>
	<li>Add 5 &#181;L of biotinylated anti-human Ab cocktail specific to blood cells (for the negative selection of B cells) per 106 cells and incubate on ice for 30 min. 
	NOTE: The anti-human Ab cocktail should at least include Abs specific to CD2 (or CD3), CD14, and CD16.</li>
	<li>Add a 10-fold excess volume of sterile PBS to the cells, centrifuge at 600 x g for 5 min, and discard the supernatant.</li>
	<li>Add equal amounts of streptavidin-conjugated microbeads (5 &#181;L per 106 cells) to the pellet and mix thoroughly.</li>
	<li>Incubate on ice for 30 min in a 15-mL plastic conical tube.</li>
	<li>Add 2 mL of PBS buffer into the tube.</li>
	<li>Place the tube into a magnetic stand and incubate at RT for 8 min. The brown microbeads will gradually attach to the tube wall next to the magnet.</li>
	<li>With the tube remaining in the magnetic stand, carefully transfer the supernatant into a new sterile 15-mL tube.</li>
	<li>Repeat steps 1.14 to 1.16 and combine the two supernatants that contain the untouched B cells. Discard the microbeads.</li>
	<li>Centrifuge at 600 x g at RT for 5 min. Discard the supernatant.</li>
	<li>Resuspend the pellet in RPMI 1640 medium for downstream experiments. 
	NOTE: Typically, 1 - 5 x 105 B cells with a purity greater than 95% from 10 mL of peripheral blood can be isolated.</li>
</ol>

<table><tbody><tr><td>BD Vacutainer K2E</td><td>BD Biosciences</td><td>367525</td><td>10 ml tube</td></tr><tr><td>Ficoll-Paque Plus</td><td>GE Healthcare</td><td>17-1440-02</td><td>Endotoxin-free</td></tr><tr><td>Trypan blue 0.5% solution</td><td>Biological Industries</td><td>03-102-1B</td><td>Dye</td></tr><tr><td>IMag Human B lymphocyte enrichment set</td><td>BD Biosciences</td><td>558007</td><td>Reagent</td></tr><tr><td>Streptavidin magnetic microbeads</td><td>BD Biosciences</td><td>9000810</td><td>Reagent</td></tr><tr><td>15 ml Falcon tubes</td><td>BD Falcon</td><td>352196</td><td>Plastic ware</td></tr><tr><td>Biotinylated CD27 mAb</td><td>Biolegend</td><td>302804</td><td>Clone O323</td></tr><tr><td>Biotinylated anti-human CD27</td><td>Biolegend</td><td>302804</td><td>Clone O323</td></tr><tr><td>Biotinylated anti-human CD27</td><td>eBioscience</td><td>13-0279-80</td><td>Clone O323</td></tr></tbody></table>

isolation and purification of b cells from human peripheral blood

Source: Tzeng, S. J. <a href="https://app.jove.com/v/54582">The Isolation, Differentiation, and Quantification of Human Antibody-secreting B Cells from Blood: ELISpot as a Functional Readout of Humoral Immunity.</a> J. Vis. Exp. (2016)
In this video, we demonstrate the isolation of B cells from human peripheral blood using biotinylated antibodies specific for non-B cells and streptavidin-conjugated magnetic microbeads.

Isolation and Purification of B Cells from Human Peripheral Blood

Source: Tzeng, S. J. The Isolation, Differentiation, and Quantification of Human Antibody-secreting B Cells from Blood: ELISpot as a Functional Readout of ...

To perform immunomagnetic negative separation of B cells, collect human peripheral blood in an anticoagulant-containing tube to prevent blood clotting. Add red blood cell, RBC, lysis buffer to lyse the RBCs without affecting other blood cells.
Centrifuge to sediment the intact, denser blood cells from the less dense lysed RBCs, which remain in the supernatant. Discard the supernatant. Resuspend the pellet in fresh medium.
Transfer the cells to a culture plate. Incubate to allow the macrophages and monocytes to adhere to the plate while the non-adherent cells, including B cells, remain in suspension.
Collect the cells in suspension into a fresh tube. Centrifuge to pellet the cells and resuspend them in a buffer.
Add a cocktail solution containing biotinylated antibodies specific for blood cells other than B cells. The antibodies bind to antigens on the surface of non-B cells, leaving the B cells unlabeled.
Centrifuge. Discard the supernatant containing unbound antibodies.
Add a solution of streptavidin-conjugated magnetic beads. During incubation, the streptavidin on the microbeads binds tightly to the biotinylated antibodies bound to non-B cells, forming complexes.
Place the tube in a magnetic field to adhere the magnetic beads-bound non-B cells to the tube walls, leaving the B cells in suspension. Transfer the supernatant containing pure B cells to a tube.
Centrifuge and resuspend the B cells in medium for further downstream analysis.

isolation-and-purification-of-b-cells-from-human-peripheral-blood

Research

JoVE Encyclopedia of Experiments

Immunology

Immune Systems and Components

Cell Isolation and Culture

240 Views. Źródło: Tzeng, S. J. Izolacja, różnicowanie i kwantyfikacja ludzkich komórek B wydzielających przeciwciała z krwi: ELISpot jako funkcjonalny odczyt odporności humoralnej. J. Vis. Exp. (2016) W tym filmie pokazujemy izolację limfocytów B z ludzkiej krwi obwodowej za pomocą biotynylowanych przeciwciał specyficznych dla komórek innych niż B oraz mikrokulek magnetycznych sprzężonych ze streptawidyną. 

Video: Izolacja i oczyszczanie limfocytów B z ludzkiej krwi obwodowej - Concept

A Simple Red Blood Cell Lysis Method for the Establishment of B Lymphoblastoid Cell Lines

A number of methods exist for the transformation of B lymphocytes by the Epstein Barr virus in vitro into immortalized cell lines. We have developed a new method with a powerful and simple strategy for the establishment of B-LCLs, the red blood cell lysis method. This method simplified the PBMC separation procedure with red blood cell removal, and used as little as 0.5 mL of whole blood for establishing EBV-immortalized cell lines, which can proliferate to large cell numbers in a relatively short amount time with a 100% success rate. The method is simple, reliable, time saving, and applicable to treating a large number of the clinical samples.

A simple red blood cell lysis method for establishing B-LCLs was developed with high immortalization efficiency, requiring a small amount of blood and saving time from initiation to cryopreservation.

A number of methods exist for the transformation of B lymphocytes by the Epstein Barr virus in vitro into immortalized cell lines. We have developed a new ...

JoVE Journal

Immunology and Infection

Detection and Enrichment of Rare Antigen-specific B Cells for Analysis of Phenotype and Function

B cells reactive with a specific antigen usually occur at a frequency of &lt;0.05% of lymphocytes. For decades researchers have sought methods to isolate and enrich these rare cells for studies of their phenotype and biology. Approaches are inevitably based on the principle that B cells recognize native antigen by virtue of cell surface receptors that are representative in specificity of antibodies that will eventually be secreted by their differentiated daughters. Perhaps the most obvious approach to the problem involves use of fluorochrome-conjugated antigens in conjunction with fluorescence-activated cell sorting (FACS). However, the utility of these methods is limited by cell frequency and the achievable rate of analysis and isolation by electronic sorting. A novel method to enrich rare antigen-specific B cells using magnetic nanoparticles that results in high yield enrichment of antigen-reactive B cells from large starting cell populations is described. This method enables improved monitoring of the phenotype and biology of antigen reactive cells before and following in vivo antigen encounter, such as after immunization or during development of autoimmunity.

A simple yet effective method that employs magnetic nanoparticles to detect and enrich antigen-reactive B cells for functional and phenotypic analysis is described.

B cells reactive with a specific antigen usually occur at a frequency of &lt;0.05% of lymphocytes. For decades researchers have sought methods to isolate ...

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells

Plasma cells (PCs) secrete large amounts of antibodies and develop from B cells that have been activated. PCs are rare cells located in the bone marrow or mucosa and ensure humoral immunity. Due to their low frequency and location, the study of PCs is difficult in human. We reported a B to PC in vitro differentiation model using selected combinations of cytokines and activation molecules that allow to reproduce the sequential cell differentiation occurring in vivo. In this in vitro model, memory B cells (MBCs) will differentiate into pre-plasmablasts (prePBs), plasmablasts (PBs), early PCs and finally, into long-lived PCs, with a phenotype close to their counterparts in healthy individuals.&#160;We also built an open access bioinformatics tools to analyze the most prominent information from GEP data related to PC differentiation. These resources can be used to study human B to PC differentiation and in the current study, we investigated the gene expression regulation of epigenetic factors during human B to PC differentiation.

Using multi-step culture systems, we report an in vitro B cell to plasma cell differentiation model.

Plasma cells (PCs) secrete large amounts of antibodies and develop from B cells that have been activated. PCs are rare cells located in the bone marrow or ...

Isolation and Purification of B Cells from Human Peripheral Blood

Transkrypcja

Isolation and Purification of B Cells from Human Peripheral Blood